280 related articles for article (PubMed ID: 25735476)
1. Altered axonal excitability properties and nerve edema in POEMS syndrome.
Mitsuma S; Misawa S; Shibuya K; Isose S; Sekiguchi Y; Iwai Y; Beppu M; Watanabe K; Amino H; Kuwabara S
Clin Neurophysiol; 2015 Oct; 126(10):2014-8. PubMed ID: 25735476
[TBL] [Abstract][Full Text] [Related]
2. Patterns of nerve conduction abnormalities in POEMS syndrome.
Sung JY; Kuwabara S; Ogawara K; Kanai K; Hattori T
Muscle Nerve; 2002 Aug; 26(2):189-93. PubMed ID: 12210381
[TBL] [Abstract][Full Text] [Related]
3. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
Misawa S
Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
[TBL] [Abstract][Full Text] [Related]
4. Polyneuropathy in POEMS syndrome: Alterations in nerve function and morphology.
Krishnan AV
Clin Neurophysiol; 2015 Oct; 126(10):1845-6. PubMed ID: 25708722
[No Abstract] [Full Text] [Related]
5. Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP.
Mauermann ML; Sorenson EJ; Dispenzieri A; Mandrekar J; Suarez GA; Dyck PJ; Dyck PJ
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):480-6. PubMed ID: 22396441
[TBL] [Abstract][Full Text] [Related]
6. Motor nerve conduction study and muscle strength in newly diagnosed POEMS syndrome.
Liu M; Zou Z; Guan Y; Li J; Zhou D; Cui L
Muscle Nerve; 2015 Jan; 51(1):19-23. PubMed ID: 24752623
[TBL] [Abstract][Full Text] [Related]
7. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic features of POEMS syndrome compared with MGUS-related neuropathy.
Kim H; Lim YM; Jin JY; Yoon DH; Suh C; Kim SY; Jo JC; Kim KK
Muscle Nerve; 2017 Dec; 56(6):E73-E77. PubMed ID: 28472865
[TBL] [Abstract][Full Text] [Related]
9. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Suzuki Y; Kikkawa Y; Sawai S; Hattori T; Nishimura M; Nakaseko C
Neurology; 2008 Nov; 71(21):1691-5. PubMed ID: 18832140
[TBL] [Abstract][Full Text] [Related]
10. POEMS syndrome with prominent acute axonal lesions.
Mathis S; Magy L; Kaboré R; Faugeras F; Richard L; Vallat JM
J Neurol Sci; 2012 Feb; 313(1-2):185-8. PubMed ID: 21982617
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Guo X; Qin X; Zhang Y; Huang C; Yu G
J Clin Neurosci; 2014 Apr; 21(4):587-90. PubMed ID: 24268501
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological features of patients with POEMS syndrome.
Min JH; Hong YH; Lee KW
Clin Neurophysiol; 2005 Apr; 116(4):965-8. PubMed ID: 15792906
[TBL] [Abstract][Full Text] [Related]
13. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome.
Kanai K; Sawai S; Sogawa K; Mori M; Misawa S; Shibuya K; Isose S; Fujimaki Y; Noto Y; Sekiguchi Y; Nasu S; Nakaseko C; Takano S; Yoshitomi H; Miyazaki M; Nomura F; Kuwabara S
Neurology; 2012 Aug; 79(6):575-82. PubMed ID: 22843279
[TBL] [Abstract][Full Text] [Related]
14. [Neurophysiologic studies of POEMS syndrome and its related diseases].
Xu Y; Song H; Zhang S; Fan D
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):356-8. PubMed ID: 24746082
[TBL] [Abstract][Full Text] [Related]
15. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration.
Sawai S; Kanai K; Nakata M; Hiraga A; Misawa S; Isose S; Hattori T; Kuwabara S
Clin Neurophysiol; 2008 May; 119(5):1097-105. PubMed ID: 18342570
[TBL] [Abstract][Full Text] [Related]
16. [Crow-Fukase syndrome and VEGF].
Arimura K; Hashiguchi T; Watanabe O
Brain Nerve; 2008 Jun; 60(6):611-9. PubMed ID: 18567356
[TBL] [Abstract][Full Text] [Related]
17. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
Wang W; Litchy WJ; Mauermann ML; Dyck PJB; Dispenzieri A; Mandrekar J; Dyck PJ; Klein CJ
Muscle Nerve; 2018 Jan; 57(1):E8-E13. PubMed ID: 28646568
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study.
Briani C; Dalla Torre C; Lessi F; Cavallaro T; Scarlato M; Ferrari S; Campagnolo M; Lucchetta M; Cabrini I; Morbin M; Lauria G; Adami F; Manfredi AA
J Neuroimmunol; 2014 Dec; 277(1-2):189-92. PubMed ID: 25447599
[TBL] [Abstract][Full Text] [Related]
19. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage.
Kanai K; Kuwabara S; Misawa S; Tamura N; Ogawara K; Nakata M; Sawai S; Hattori T; Bostock H
Brain; 2006 Apr; 129(Pt 4):953-62. PubMed ID: 16467388
[TBL] [Abstract][Full Text] [Related]
20. POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification.
Araki N; Misawa S; Shibuya K; Ota S; Oide T; Kawano A; Beppu M; Nakatani Y; Kuwabara S
Orphanet J Rare Dis; 2016 Apr; 11():35. PubMed ID: 27068711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
